Effect of caspofungin on patients with hematologic malignancies and invasive fungal infections
-
-
Key words:
- hematologic malignancies /
- invasive fungal infections /
- caspofungin
-
-
[1] PAGANO L,CAIRA M,VALENTINI C G,et al.Current therapeutic approaches to fungal infections in immunocompromised hematological patients[J].Blood Rev,2010,24:51-61.
[2] 中国侵袭性真菌感染工作组.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(第三次修订)[J].中华内科杂志,2010,49(5):45l-454.
[3] BORECKÁ S,PINJON E,SULLIVAN D J,et al.Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates[J].Can J Microbiol,2011,57:416-426.
[4] SCHULER U,BAMMER S,AULITZKY W E,et al.Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy[J].Onkologie,2007,30:185-191.
[5] 陈懿建,张立群,万通,等.两性霉素B脂质体治疗恶性血液病侵袭性真菌感染的临床观察[J].临床血液学杂志,2011,24(11):683-685.
[6] 王海燕,崔杰,黄祥,等.卡泊芬净治疗老年患者侵袭性真菌感染临床分析[J].中国药物应用与监测,2009,6(5):266-269.
[7] JOSEPH J M,JAIN R,DANZIGER L H.Micafungin:a new echinocandin antifungal[J].Pharmacotherapy,2007,27:53-67.
[8] NAKAGAWA Y,LCHII Y,SAEKI Y,et al.Plasma concentration of micafungin in patients with hematologic malignancies[J].J Infect Chemother,2007,13:39-45.
[9] GLOCKNER A,STEINBACH A,VEHRESCHILD J J,et al.Treatment of invasive candidiasis with echinocandins[J].Mycoses,2009,52:476-486.
-
计量
- 文章访问数: 45
- PDF下载数: 228
- 施引文献: 0